Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hemophilia
100%
Hemophilia B
88%
Factor 9
85%
Bleeding
69%
Pediatric
44%
Unfractionated Heparin
44%
Patients with Haemophilia
44%
Bleeding Disorders
38%
X-linked
35%
Plasma Factors
35%
Inhibitory Antibody
35%
Pediatric Population
29%
Anaphylaxis
29%
Recurrent Bleeding
29%
Postsurgical
29%
Oral Tissues
29%
Soft-tissue Bleeding
29%
Intramuscular Hemorrhage
29%
Inhibitor Development
29%
Partial Thromboplastin Time
25%
Anti-FXa
25%
Observational Cohort Study
25%
Gene Therapy
24%
Male Births
24%
Severe Haemophilia A
22%
Consumptive Coagulopathy
22%
Newly Diagnosed
22%
Kaposiform Lymphangiomatosis
22%
Dose Capping
22%
Subhyaloid Hemorrhage
22%
MiR-1246
22%
Factor VIII Gene
22%
Disease Analysis
22%
Anti-factor Xa
22%
Von Willebrand Disease
22%
Small ncRNAs
22%
Efficacy Study
22%
Sickle Cell Disease
22%
Haemophilia with Inhibitors
22%
Expression Profiling
22%
Factor XI Deficiency
22%
Joint Hemorrhage
22%
Thrombotic
22%
Von Willebrand Factor Cleaving Protease
22%
Cutaneous Lymphoproliferative Disorder
22%
Thrombosis
22%
Aneurysm
22%
Response Characteristics
22%
Product Characteristics
22%
Bypassing Agents
22%
Medicine and Dentistry
Bleeding
67%
Haemophilia A
44%
Disseminated Intravascular Coagulation
44%
Disseminated Intravascular Clotting
44%
Quality of Life
37%
Hemostat
33%
Diseases
31%
Pediatrics
26%
Lymphangiomatosis
22%
Immunoglobulin M Deficiency
22%
Coagulopathy
22%
Unruptured Intracranial Aneurysm
22%
Post-Thrombotic Syndrome
22%
Sickle-Cell Disease
22%
Aneurysm
22%
Evans Syndrome
22%
Intracranial Aneurysm
22%
Efficacy Study
22%
Von Willebrand Disease
22%
Lymphoproliferative Disease
22%
Tranexamic Acid
22%
Menorrhagia
22%
Arm
22%
Pericardial Fluid
22%
Thrombosis
22%
Factor XI
22%
Adolescence
22%
Blood Clotting Factor 8
18%
Bleeding
16%
Lymphomatoid Papulosis
14%
Pleura Effusion
14%
Chemotherapy
14%
Antifibrinolytic
14%
Rib Resection
13%
Anticoagulation
13%
Magnetic Resonance Angiography
13%
Fibrinolytic Therapy
13%
Magnetic Resonance Imaging
13%
Patient with Hemophilia
11%
Immunological Tolerance
11%
Morbidity
11%
Oral
9%
Visual Impairment
8%
Thrombus
8%
Plasma Factor
7%
Bleeding Disorder
7%
Coagulation Factor VIII
7%
Hematological Cancer
7%
Lymph Duct
7%
Memory B Cell
7%